Syrosingopine

Overview

Syrosingopine (Su 3118) is an orally active lactate transporters ( MCT1/MCT4 ) dual inhibitor, which can reduce glycolysis and induce synthetic lethality in cancer cells when combine with metformin. Syrosingopine shows anti-hypertensive activity by depleting peripheral stores of norepinephrine.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Hypertension | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > Monocarboxylate Transporter

Product Information

• Catalog No.: HY-N4115
• CAS No.: 84-36-6
• Molecular Formula: C35H42N2O11
• Molecular Weight: 666.71
• Purity: 99.52%
• Storage: 4°C, protect from light * In solvent : -80°C, 2 years; -20°C, 1 year (protect from light)
• Solubility: ≥ 2.08 mg/mL (3.12 mM); Clear solution
• Availability: In-stock

Source

Original product source